Plasmodium falciparum hypoxanthine guanine phosphoribosyltransferase: Stability studies on the product-activated enzyme

FEBS Journal

Volumn 272, Issue 8, 2005, Pages 1900-1911

  Raman, Jayalakshmi ^a   Ashok, Chethan S ^a   Subbayya, Sujay I N ^a   Anand, Ranjith P ^a   Selvi, Senthamizh T ^a   Balaram, Hemalatha ^a  

^a JAWAHARLAL NEHRU CENTRE FOR ADVANCED SCIENTIFIC RESEARCH   (India)

Author keywords

Active state stability; Hypoxanthine guanine phosphoribosyltransferase; Plasmodium falciparum; Product activation; Thermal stability

Indexed keywords

HYPOXANTHINE; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; INOSINE PHOSPHATE; LIGAND; NUCLEOTIDE; PHOSPHORIBOSYL PYROPHOSPHATE;

ARTICLE; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME MECHANISM; ENZYME PURIFICATION; ENZYME STABILITY; ENZYME SUBSTRATE; NONHUMAN; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; TEMPERATURE SENSITIVE MUTANT;

ANIMALS; CIRCULAR DICHROISM; ENZYME ACTIVATION; ENZYME STABILITY; GUANIDINE; HUMANS; HYPOXANTHINE; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; INOSINE MONOPHOSPHATE; MODELS, MOLECULAR; PLASMODIUM FALCIPARUM; PROTEIN CONFORMATION; PROTEIN DENATURATION; PROTEIN FOLDING; TEMPERATURE; THERMODYNAMICS;

EID: 17444423642     PISSN: 1742464X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1742-4658.2005.04620.x     Document Type: Article

References (51)

1. Salerno C & Giacomello A (1981) Human hypoxanthine guanine phosphoribosyltransferase. The role of magnesium ion in a phosphoribosylpyrophosphate-utilizing enzyme. J Biol Chem 256, 3671-3673.
2. Ullman B & Carter D (1995) Hypoxanthine-guanine phosphoribosyltransferase as a therapeutic target in protozoal infections. Infect Agents Dis 4, 29-40.
3. Sherman IW (1979) Biochemistry of Plasmodium (malarial parasites). Microbiol Rev 43, 453-495.
4. Berman PA, Human L & Freese JA (1991) Xanthine oxidase inhibits growth of Plasmodium falciparum in human erythrocytes in vitro. J Clin Invest 88, 1848-1855.
5. Reyes P, Rathod PK, Sanchez DJ, Mrema JE, Rieckmann KH & Heidrich HG (1982) Enzymes of purine and pyrimidine metabolism from the human malaria parasite, Plasmodium falciparum. Mol Biochem Parasitol 5, 275-290.
6. Queen SA, Vander Jagt DL & Reyes P (1989) Characterization of adenine phosphoribosyltransferase from the human malaria parasite, Plasmodium falciparum. Biochim Biophys Acta 996, 160-165.
7. Gardner MJ, Hall N, Fung E, White O, Berriman M, Hyman RW, Carlton JM, Pain A, Nelson KE, Bowman S et al. (2002) Genome sequence of the human malaria parasite Plasmodium falciparum. Nature 419, 498-511.
8. Queen SA, Jagt DL & Reyes P (1990) In vitro susceptibilities of Plasmodium falciparum to compounds which inhibit nucleotide metabolism. Antimicrob Agents Chemother 34, 1393-1398.
9. Dawson PA, Cochran DA, Emmerson BT & Gordon RB (1993) Inhibition of Plasmodium falciparum hypoxanthine-guanine phosphoribosyltransferase mRNA by antisense oligodeoxynucleotide sequence. Mol Biochem Parasitol 153-156.
10. Kanagaratnam R, Misiura K, Rebowski G & Ramasamy R (1998) Malaria merozoite surface protein antisense oligodeoxynucleotides lack antisense activity but function as polyanions to inhibit red cell invasion. Int J Biochem Cell Biol 30, 979-985.
11. Ramasamy R, Kanagaratnam R, Misiura K, Rebowski G, Amerakoon R & Stec WJ (1996) Anti-sense oligodeoxynucleoside phosphorothioates nonspecifically inhibit invasion of red blood cells by malaria parasites. Biochem Biophys Res Commun 218, 930-933.
12. Clark DL, Chrisey LA, Campbell JR & Davidson EA (1994) Non-sequence-specific antimalarial activity of oligodeoxynucleotides. Mol Biochem Parasitol 63, 129-134.
13. Barker RH Jr, Metelev V, Rapaport E & Zamecnik P (1996) Inhibition of Plasmodium falciparum malaria using antisense oligodeoxynucleotides. Proc Natl Acad Sci USA 93, 514-518.
14. Lesch M & Nyhan WL (1964) A familial disorder of uric acid metabolism and central nervous system function. Am J Med 36, 561-570.
15. Jinnah HA, De Gregorio L, Harris JC, Nyhan WL & O'Neill JP (2000) The spectrum of inherited mutations causing HPRT deficiency: 75 new cases and a review of 196 previously reported cases. Mutat Res 463, 309-326.
16. Xu Y & Grubmeyer C (1998) Catalysis in human hypoxanthine-guanine phosphoribosyltransferase: Asp 137 acts as a general acid/base. Biochemistry 37, 4114-4124.
17. Yuan L, Craig SP, McKerrow JH & Wang CC (1992) Steady-state kinetics of the schistosomal hypoxanthine-guanine phosphoribosyltransferase. Biochemistry 31, 806-810.
18. Li CM, Tyler PC, Furneaux RH, Kicska G, Xu Y, Grubmeyer C, Girvin ME & Schramm VL (1999) Transition-state analogs as inhibitors of human and malarial hypoxanthine-guanine phosphoribosyltransferases. Nat Struct Biol 6, 582-587.
19. Munagala NR, Chin MS & Wang CC (1998) Steady-state kinetics of the hypoxanthine-guanine-xanthine phosphoribosyltransferase from Tritrichomonas foetus: the role of threonine-47. Biochemistry 37, 4045-4051.
20. Wenck MA, Medrano FJ, Eakin AE & Craig SP (2004) Steady-state kinetics of the hypoxanthine guanine phosphoribosyltransferase from Trypanosoma cruzi. Biochim Biophys Acta 1700, 11-18.
21. Shi W, Li CM, Tyler PC, Furneaux RH, Grubmeyer C, Schramm VL & Almo SC (1999) The 2.0 Å structure of human hypoxanthine-guanine phosphoribosyltransferase in complex with a transition-state analog inhibitor. Nat Struct Biol 6, 588-593.
22. Shi W, Li CM, Tyler PC, Furneaux RH, Cahill SM, Girvin ME, Grubmeyer C, Schramm VL & Almo SC (1999) The 2.0 Å structure of malarial purine phosphoribosyltransferase in complex with a transition-state analogue inhibitor. Biochemistry 38, 9872-9880.
23. Queen SA, Vander Jagt D & Reyes P (1988) Properties and substrate specificity of a purine phosphoribosyltransferase from the human malaria parasite, Plasmodium falciparum. Mol Biochem Parasitol 30, 123-133.
24. Munagala NR & Wang CC (1998) Altering the purine specificity of hypoxanthine-guanine-xanthine phosphoribosyltransferase from Tritrichomonas foetus by structure-based point mutations in the enzyme protein. Biochemistry 37, 16612-16619.
25. Raman J, Sumathy K, Anand RP & Balaram H (2004) A non-active site mutation in human hypoxanthine guanine phosphoribosyltransferase expands substrate specificity. Arch Biochem Biophys 427, 116-122.
26. Sujay Subbayya IN, Sukumaran S, Shivashankar K & Balaram H (2000) Unusual substrate specificity of a chimeric hypoxanthine-guanine phosphoribosyltransferase containing segments from the Plasmodium falciparum and human enzymes. Biochem Biophys Res Commun 272, 596-602.
27. Eakin AE, Guerra A, Focia PJ, Torres-Martinez J & Craig SP (1997) Hypoxanthine phosphoribosyltransferase from Trypanosoma cruzi as a target for structure-based inhibitor design: crystallization and inhibition studies with purine analogs. Antimicrob Agents Chemother 41, 1686-1692.
28. Yuan L, Craig SP, McKerrow JH & Wang CC (1990) The hypoxanthine-guanine phosphoribosyltransferase of Schistosoma mansoni. Further characterization and gene expression in Escherichia coli. J Biol Chem 265, 13528-13532.
29. Heroux A, White EL, Ross LJ & Borhani DW (1999) Crystal structures of the Toxoplasma gondii hypoxanthine-guanine phosphoribosyltransferase-GMP and -IMP complexes: comparison of purine binding interactions with the XMP complex. Biochemistry 38, 14485-14494.
30. Keough DT, Ng AL, Winzor DJ, Emmerson BT & de Jersey J (1999) Purification and characterization of Plasmodium falciparum hypoxanthine-guanine- xanthine phosphoribosyltransferase and comparison with the human enzyme. Mol Biochem Parasitol 98, 29-41.
31. Sujay Subbayya IN & Balaram H (2000) Evidence for multiple active states of Plasmodium falciparum hypoxanthine-guanine-xanthine phosphoribosyltransferase. Biochem Biophys Res Commun 279, 433-437.
32. Olliaro PL & Yuthavong Y (1999) An overview of chemotherapeutic targets for antimalarial drug discovery. Pharmacol Ther 81, 91-110.
33. Jochimsen B, Nygaard P & Vestergaard T (1975) Location on the chromosome of Escherichia coli of genes governing purine metabolism. Adenosine deaminase (add), guanosine kinase (gsk) and hypoxanthine phosphoribosyltransferase (hpt). Mol Gen Genet 143, 85-91.
34. Shivashankar K, Subbayya IN & Balaram H (2001) Development of a bacterial screen for novel hypoxanthine-guanine phosphoribosyltransferase substrates. J Mol Microbiol Biotechnol 3, 557-562.
35. Lee C, Park SH, Lee MY & Yu MH (2002) Regulation of protein function by native metastability. Proc Natl Acad Sci USA 97, 7727-7731.
36. Wang Z, Mottonen J & Goldsmith EJ (1996) Kinetically controlled folding of the serpin plasminogen activator inhibitor 1. Biochemistry 35, 16443-16448.
37. Cunningham EL, Jaswal SS, Sohl JL & Agard DA (1999) Kinetic stability as a mechanism for protease longevity. Proc Natl Acad Sci USA 96, 11008-11014.
38. Jaswal SS, Sohl JL, Davis JH & Agard DA (2002) Energetic landscape of alpha-lytic protease optimizes longevity through kinetic stability. Nature 415, 343-346.
39. Sohl JL, Jaswal SS & Agard DA (1998) Unfolded conformations of alpha-lytic protease are more stable than its native state. Nature 395, 817-819.
40. Lightfoot T, Lewkonia RM & Snyder FF (1994) Sequence, expression and characterization of HPRTMoose Jaw: a point mutation resulting in cooperativity and decreased substrate affinities. Hum Mol Genet 3, 1377-1381.
41. 2+ and the inhibitor HPP reveals the involvement of the flexible loop in substrate binding. Protein Sci 8, 1023-1031.
42. Focia PJ, Craig SP III & Eakin AE (1998) Approaching the transition state in the crystal structure of a phosphoribosyltransferase. Biochemistry 37, 17120-17127.
43. Focia PJ, Craig SP III, Nieves-Alicea R, Fletterick RJ & Eakin AE (1998) A 1.4 Å crystal structure for the hypoxanthine phosphoribosyltransferase of Trypanosoma cruzi. Biochemistry 37, 15066-15075.
44. 2+ ions bound: insights into the catalytic mechanism. Biochemistry 38, 14495-14506.
45. Carr CM, Chaudhry C & Kim PS (1997) Influenza hemagglutinin is spring-loaded by a metastable native conformation. Proc Natl Acad Sci USA 94, 14306-14313.
46. Smith JG, Mothes W, Blacklow SC & Cunningham JM (2004) The mature avian leukosis virus subgroup A envelope glycoprotein is metastable, and refolding induced by the synergistic effects of receptor binding and low pH is coupled to infection. J Virol 78, 1403-1410.
47. Stiasny K, Allison SL, Mandl CW & Heinz FX (2001) Role of metastability and acidic pH in membrane fusion by tick-borne encephalitis virus. J Virol 75, 7392-7398.
48. Lebreton S & Gontero B (1999) Memory and imprinting in multienzyme complexes. Evidence for information transfer from glyceraldehyde-3-phosphate dehydrogenase to phosphoribulokinase under reduced state in Chlamydomonas reinhardtii. J Biol Chem 274, 20879-20884.
49. Pollack Y, Katzen AL, Spira DT & Golenser J (1982) The genome of Plasmodium falciparum. I: DNA base composition. Nucleic Acids Res 10, 539-546.
50. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72, 248-254.
51. Giacomello A & Salerno C (1977) A continuous spectrophotometric assay for hypoxanthine-guanine phosphoribosyltransferase. Anal Biochem 79, 263-267.